(Q63578411)

English

A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis

clinical trial

Statements

ADmIRe (English)
0 references
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3375880 in Adult Subjects With Moderate-to-Severe Atopic Dermatitis: The ADmIRe Study (English)
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
12 February 2019
0 references
14 February 2020
0 references
200
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit